CoChat

Mice with hyper-long telomeres show less metabolic aging and longer lifespans

Muñoz-Lorente, Miguel A., Cano-Martin, Alba C., Blasco, Maria A. · 2019 · Nature Communications
Cited by 154

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Short telomeres trigger age-related pathologies and shorter lifespans in mice and humans. In the past, we generated mouse embryonic (ES) cells with longer telomeres than normal (hyper-long telomeres) in the absence of genetic manipulations, which contributed to all mouse tissues. To address whether hyper-long telomeres have deleterious effects, we generated mice in which 100% of their cells are derived from hyper-long telomere ES cells. We observe that these mice have longer telomeres and less DNA damage with aging. Hyper-long telomere mice are lean and show low cholesterol and LDL levels, as well as improved glucose and insulin tolerance. Hyper-long telomere mice also have less incidence of cancer and an increased longevity. These findings demonstrate that longer telomeres than normal in a given species are not deleterious but instead, show beneficial effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-12664-x

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Hyper-long telomere mice are leaner than normal mice. a Scheme showing generation of mice with hyper-long telomeres. eGFP ES cells are cultured in 2i medium until passage 16 and they are microinjected into morulae to obtain 100% contributing chimaeras. b Representative images showing 100% eGFP ES cell contribution in different organs and tissues. c, d Longitudinal follow up of weight in the indicated cohorts. Hyper-long telomere mice show a significant reduction in body weight from 40 weeks onwards (c) and this body size reduction is maintained until the last timepoint measured (c, d). Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. Source data are provided as a Source Data file
Fig. 1 Hyper-long telomere mice are leaner than normal mice. a Scheme showing generation of mice with hyper-long telomeres. eGFP ES cells are cultured in 2i medium until passage 16 and they are microinjected into morulae to obtain 100% contributing chimaeras. b Representative images showing 100% eGFP ES cell contribution in different organs and tissues. c, d Longitudinal follow up of weight in the indicated cohorts. Hyper-long telomere mice show a significant reduction in body weight from 40 weeks onwards (c) and this body size reduction is maintained until the last timepoint measured (c, d). Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 2 Reduced body size in hyper-long telomere mice is due to lower fat accumulation. a–c Densitometry analysis of hyper-long telomere mice and normal mice at two different ages. a Quantification of percentage of total fat. b Quantification of bone density. c Quantification of total lean mass. d, e Quantification of the skin subcutaneous fat layer in 100 weeks-old hyper-long mice and age-matched controls (d), and representative image showing skin subcutaneous fat layer thickness. Measurements were done by ImageJ software and calculated by the mean value of 30–40 different measurements all over the skin subcutaneous fat layer. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. ***p < 0.001. Source data are provided as a Source Data file
Fig. 2 Reduced body size in hyper-long telomere mice is due to lower fat accumulation. a–c Densitometry analysis of hyper-long telomere mice and normal mice at two different ages. a Quantification of percentage of total fat. b Quantification of bone density. c Quantification of total lean mass. d, e Quantification of the skin subcutaneous fat layer in 100 weeks-old hyper-long mice and age-matched controls (d), and representative image showing skin subcutaneous fat layer thickness. Measurements were done by ImageJ software and calculated by the mean value of 30–40 different measurements all over the skin subcutaneous fat layer. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. ***p < 0.001. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 3 Hyper-long telomere mice show less metabolic aging. a–h Pentra quantification of different serum metabolites at 50, 75, and 100 weeks-old. Metabolites were measured in serum obtained from blood extracts using ABX Pentra, a quantification of creatinine levels, b quantification of total bilirubin levels, c quantification of albumin levels, d quantification of urea levels, e quantification of HDL (high density lipoprotein) levels, f quantification of LDL (low density lipoprotein) levels, g quantification of ALT (alanine aminotransferase) levels and h quantification of cholesterol levels. i–k Glucose tolerance test (GTT). GTT was performed in hyper-long telomere mice and age-matched controls at 50 (i), 75 (j) and 100 (k) weeks of age by intraperitoneal glucose injection after 16 h fasting. l–n Insulin tolerance test (ITT). ITT was performed in hyper-long telomere mice and age-matched controls at 50 (l), 75 (m) and 100 (n) weeks of age by intraperitoneal insulin injection. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. ***p < 0.001. Source data are provided as a Source Data file
Fig. 3 Hyper-long telomere mice show less metabolic aging. a–h Pentra quantification of different serum metabolites at 50, 75, and 100 weeks-old. Metabolites were measured in serum obtained from blood extracts using ABX Pentra, a quantification of creatinine levels, b quantification of total bilirubin levels, c quantification of albumin levels, d quantification of urea levels, e quantification of HDL (high density lipoprotein) levels, f quantification of LDL (low density lipoprotein) levels, g quantification of ALT (alanine aminotransferase) levels and h quantification of cholesterol levels. i–k Glucose tolerance test (GTT). GTT was performed in hyper-long telomere mice and age-matched controls at 50 (i), 75 (j) and 100 (k) weeks of age by intraperitoneal glucose injection after 16 h fasting. l–n Insulin tolerance test (ITT). ITT was performed in hyper-long telomere mice and age-matched controls at 50 (l), 75 (m) and 100 (n) weeks of age by intraperitoneal insulin injection. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. ***p < 0.001. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 4 Hyper-long telomere mice live longer and have less spontaneous cancer. a Survival proportions of 100% hyper-long chimeric mice compared to control mice from the same background. Hyper-long telomere mice show a 12.75% increase in median lifespan and an 8.4% increase in maximum lifespan. b Quantification of spontaneous tumor incidence in hyper-long telomere mice and controls. Hyper-long telomere mice show a decrease in almost 20% in tumor incidence compared to control mice from the same background. Error bars represent standard error. Mantel–Cox test was used for statistical analysis in survival curves and Chi-square test for spontaneous tumor incidence. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. ***p < 0.001. Source data are provided as a Source Data file
Fig. 4 Hyper-long telomere mice live longer and have less spontaneous cancer. a Survival proportions of 100% hyper-long chimeric mice compared to control mice from the same background. Hyper-long telomere mice show a 12.75% increase in median lifespan and an 8.4% increase in maximum lifespan. b Quantification of spontaneous tumor incidence in hyper-long telomere mice and controls. Hyper-long telomere mice show a decrease in almost 20% in tumor incidence compared to control mice from the same background. Error bars represent standard error. Mantel–Cox test was used for statistical analysis in survival curves and Chi-square test for spontaneous tumor incidence. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. ***p < 0.001. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 5 Hyper-long telomere mice show longer telomeres throughout their lifespan in both proliferative and non-proliferative tissues. a–f Mean telomere fluorescence and percentage of short telomeres in back skin (a, b), intestine (c, d), brain (e, f) in 100 weeks-old hyper-long telomere mice and age-matched controls. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. ***p < 0.001. Source data are provided as a Source Data file
Fig. 5 Hyper-long telomere mice show longer telomeres throughout their lifespan in both proliferative and non-proliferative tissues. a–f Mean telomere fluorescence and percentage of short telomeres in back skin (a, b), intestine (c, d), brain (e, f) in 100 weeks-old hyper-long telomere mice and age-matched controls. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. ***p < 0.001. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 6 Hyper-long telomere mice show longer telomeres throughout their lifespan in metabolic-related tissues. a–f Mean telomere fluorescence and percentage of short telomeres in liver (a, b), white adipose tissue (c, d) and brown adipose tissue (e, f), in 100 weeks-old hyper-long telomere mice and age-matched controls. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0,01. ***p < 0,001. Source data are provided as a Source Data file
Fig. 6 Hyper-long telomere mice show longer telomeres throughout their lifespan in metabolic-related tissues. a–f Mean telomere fluorescence and percentage of short telomeres in liver (a, b), white adipose tissue (c, d) and brown adipose tissue (e, f), in 100 weeks-old hyper-long telomere mice and age-matched controls. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0,01. ***p < 0,001. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 7 Hyper-long telomere mice does not present altered telomerase expression levels. a–d Tert and Terc mRNA expression levels as measured by Q-PCR in liver (a, b) and in white adipose tissue (c, d) in age-matched (100 weeks old) hyper-long telomere mice and control mice. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0,01. ***p < 0,001. Source data are provided as a Source Data file
Fig. 7 Hyper-long telomere mice does not present altered telomerase expression levels. a–d Tert and Terc mRNA expression levels as measured by Q-PCR in liver (a, b) and in white adipose tissue (c, d) in age-matched (100 weeks old) hyper-long telomere mice and control mice. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0,01. ***p < 0,001. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 8 Hyper-long telomere mice show less DNA damage and less senescence. a, b Quantification of DNA damage in age-matched (100 weeks old) hyper-long telomere mice and control mice. Quantification of total damage as indicated by percentage of cells with ≥2 53BP1 foci as determined by immunofluorescence (a) and quantification of cells showing telomere-induced DNA damage as shown by percentage of cells with ≥1 TIF (telomere induced foci) as determined by telomere FISH followed by immunofluorescence with 53BP1 antibody (b). c Representative images of TIFs (yellow arrow). d Quantification of the percentage of p21 positive cells in liver of age matched (100 weeks old) hyper-long telomere mice and control mice. e Representative images of p21 (red arrows) positive cells. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. **p < 0.01. Source data are provided as a Source Data file
Fig. 8 Hyper-long telomere mice show less DNA damage and less senescence. a, b Quantification of DNA damage in age-matched (100 weeks old) hyper-long telomere mice and control mice. Quantification of total damage as indicated by percentage of cells with ≥2 53BP1 foci as determined by immunofluorescence (a) and quantification of cells showing telomere-induced DNA damage as shown by percentage of cells with ≥1 TIF (telomere induced foci) as determined by telomere FISH followed by immunofluorescence with 53BP1 antibody (b). c Representative images of TIFs (yellow arrow). d Quantification of the percentage of p21 positive cells in liver of age matched (100 weeks old) hyper-long telomere mice and control mice. e Representative images of p21 (red arrows) positive cells. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. **p < 0.01. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 9 Improved mitochondrial function in mice with hyper-long telomeres. a–c. Relative mtDNA content was calculated by the comparative Ct method of the mitochondrial genes Cox1 (a), Cytb1 (b) and Nd1 (c) compared to the nuclear gene H19 in WAT of 100–110 weeks old hyper-long telomere mice and age-matched controls. d–k. mRNA levels from WAT of the OXPHOS genes Cytochrome C (d), ATP synthase (e), Cytochrome C subunit 6 (f) and Cytochrome C subunit 5a (g) as well as mitochondrial regulators PGC-1a (h) and PGC-1b (i) and critical targets, such as ERRa (j) and PPARa (k). Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. Source data are provided as a Source Data file
Fig. 9 Improved mitochondrial function in mice with hyper-long telomeres. a–c. Relative mtDNA content was calculated by the comparative Ct method of the mitochondrial genes Cox1 (a), Cytb1 (b) and Nd1 (c) compared to the nuclear gene H19 in WAT of 100–110 weeks old hyper-long telomere mice and age-matched controls. d–k. mRNA levels from WAT of the OXPHOS genes Cytochrome C (d), ATP synthase (e), Cytochrome C subunit 6 (f) and Cytochrome C subunit 5a (g) as well as mitochondrial regulators PGC-1a (h) and PGC-1b (i) and critical targets, such as ERRa (j) and PPARa (k). Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. Source data are provided as a Source Data fileCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Research works printed but not linked: 35

  1. Martínez, P. & Blasco, M. A. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat. Rev. Cancer 11, 161–176 (2011). · DOI · Paper page
  2. Chan, S. W. L. & Blackburn, E. H. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene 21, 553–563 (2002). · DOI · Paper page
  3. Blasco, M. A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet . 6, 611–622 (2005). · DOI · Paper page
  4. Blasco, M. A., Martín-Rivera, L., Herrera, E. & Albar, J. P. Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl Acad. Sci. USA 95, 10471–10476 (1998). · DOI · Paper page
  5. Marion, R. M. & Blasco, M. A. Telomeres and telomerase in adult stem cells and pluripotent embryonic stem cells. Adv. Exp. Med. Biol. 695, 118–131 (2010). · DOI
  6. Gardner, J. P. et al. Telomere dynamics in macaques and humans. J. Gerontol. A Biol. Sci. Med. Sci. 62, 367–374 (2007). · DOI
  7. Gomes, N. M. V., Shay, J. W. & Wright, W. E. Telomere biology in Metazoa. FEBS Lett. 584, 3741–3751 (2010). · DOI · Paper page
  8. Vera, E., et al. The rate of increase of short telomeres predicts longevity in mammals. Cell Rep. 2, 732–737 (2012). · DOI · Paper page
  9. Schaetzlein, S. et al. Telomere length is reset during early mammalian embryogenesis. Proc. Natl Acad. Sci. USA 101, 8034–8038 (2004). · DOI · Paper page
  10. Varela, E., Schneider, R. P., Ortega, S. & Blasco, M. A. Different telomere-length dynamics at the inner cell mass versus established embryonic stem (ES) cells. Proc. Natl Acad. Sci. USA 108, 15207–15212 (2011). · DOI · Paper page
  11. Varela, E., Muñoz-Lorente, M. A., Tejera, A. M., Ortega, S. & Blasco, M. A. Generation of mice with longer and better preserved telomeres in the absence of genetic manipulations. Nat. Commun. 7, 11739 (2016). · DOI · Paper page
  12. Naxerova, K. & Elledge, S. J. Taking the brakes off telomerase. Elife 4, e09519 (2015). · DOI
  13. Haycock, P. C. et al. Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study. JAMA Oncol. 3, 636–651 (2017). · DOI · Paper page
  14. Missios, P. et al. Glucose substitution prolongs maintenance of energy homeostasis and lifespan of telomere dysfunctional mice. Nat. Commun. 5, 4924 (2014). · DOI
  15. Martínez, P. et al. RAP1 Protects from obesity through its extratelomeric role regulating gene expression. Cell Rep. 3, 2059–2074 (2013). · DOI
  16. Blasco, M. A., Funk, W., Villeponteau, B. & Greider, C. W. Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267–1270 (1995). · DOI · Paper page
  17. Canela, A., Vera, E., Klatt, P. & Blasco, M. A. High-throughput telomere length quantification by FISH and its application to human population studies. Proc. Natl Acad. Sci. USA 104, 5300–5305 (2007). · DOI · Paper page
  18. Blasco, M. A. et al. Mouse models for the study of telomerase. Ciba Found. Symp. 211, 160–170(1997). · DOI · Paper page
  19. Blasco, M. A. Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging. EMBO J. 24, 1095–1103 (2005). · DOI
  20. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646–674 (2011). · DOI · Paper page
  21. Hu, H., Zhang, Y., Zou, M., Yang, S. & Liang, X. Q. Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer. J. Cancer Res. Clin. Oncol. 136, 1407–1414 (2010). · DOI
  22. Newey, P. J. et al. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas. J. Clin. Endocrinol. Metab. 97, E1995–E2005 (2012). · DOI · Paper page
  23. Ramsay, A. J. et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat. Genet. 45, 526–530 (2013). · DOI · Paper page
  24. Zhang, J. et al. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood 123, 2988–2996 (2014). · DOI · Paper page
  25. Bainbridge, M. N. et al. Germline mutations in shelterin complex genes are associated with familial glioma. J. Natl. Cancer Inst. 107, 384 (2015). · DOI · Paper page
  26. Prudhomme, J. & Morey, C. Epigenesis and plasticity of mouse trophoblast stem cells. Cell. Mol. Life Sci. 73, 757–774 (2016). · DOI
  27. Baines, K. J. & Renaud, S. J. Transcription factors that regulate trophoblast development and function. Prog. Mol. Biol. Transl. Sci. 145, 39–88 (2017). · DOI
  28. Ikeno, Y., Bronson, R. T., Hubbard, G. B., Lee, S. & Bartke, A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J. Gerontol. A. Biol. Sci. Med. Sci. 58, 291–296 (2003). · DOI · Paper page
  29. Ikeno, Y. et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J. Gerontol. A Biol. Sci. Med. Sci. 64, 522–529 (2009). · DOI · Paper page
  30. Bartke, A. Single-gene mutations and healthy ageing in mammals. Philos. Trans. R Soc. Lond. B Biol. Sci. 366, 28–34 (2011). · DOI · Paper page
  31. Bartke, A. & Quainoo, N. Impact of growth hormone-related mutations on mammalian aging. Front. Genet. 9, 586 (2018). · DOI · Paper page
  32. Derevyanko, A. et al. Gene therapy with the TRF1 telomere gene rescues decreased TRF1 levels with aging and prolongs mouse health span. Aging Cell 16, 1353–1368 (2017). · DOI
  33. Yang, M. & Crawley, J. N. Simple behavioral assessment of mouse olfaction. Curr. Protoc. Neurosci. https://doi.org/10.1002/0471142301.ns0824s48 (2009). · DOI · Paper page
  34. Venegas, V. & Halberg, M. C. Measurement of mitochondrial DNA copy number. Methods Mol. Biol. 837, 327–335 (2012). · DOI
  35. Gonzalez-Hunt, C. P. et al. PCR-based analysis of mitochondrial DNA copy number, mitochondrial DNA damage, and nuclear DNA damage. Curr. Protoc. Toxicol. https://doi.org/10.1002/0471140856.tx2011s67 (2016). · DOI

Cited by

See all 154

Metadata

Authors
Muñoz-Lorente, M. A., Cano-Martin, A. C., & Blasco, M. A.
Venue
Nature Communications
Published
2019-10-17
Volume
10
Issue
1
ISSN
2041-1723
Cited by
154
References
28
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mice with hyper-long telomeres show less metabolic aging and longer lifespans. https://app.cochat.ai/papers/10.1038/s41467-019-12664-x
The paper
Muñoz-Lorente, M. A., Cano-Martin, A. C., & Blasco, M. A. (2019). Mice with hyper-long telomeres show less metabolic aging and longer lifespans. Nature Communications. https://doi.org/10.1038/s41467-019-12664-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.